ABG
Asbury Automotive Group, Inc.
ABG trails on the overall score without a compensating advantage in the available component scores.
AMZN
Amazon.com, Inc.
AMZN has the edge over ABG overall, supported by stronger modeled upside and stronger valuation.
ABG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Under pressure |
ABG's revenue, profitability and cash flow are currently stable, but its balance sheet is under pressure.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ABG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $132 | -34% |
| Forward | 7.5x | $200 | — |
| Current | 8x | $200 | — |
| Fair | 8.1x | $204 | +2.3% |
| Expensive | 12x | $300 | +50% |
Historical ranges are pointers, not guarantees.
ABG's PE is in its fair range at 8.0x. If earnings grow as analysts expect, today's price would be 7.5x next year's earnings.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ABG in the historical PE scenario, which offers more potential upside but is not a forecast.
ABG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect ABG's earnings to grow, with its revenue and profitability holding steady.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ABG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $26.59 | +5.9% |
| Q3 2026 | $25.10 | -12% |
| Q2 2026 | $26.78 | -2.2% |
| Q1 2026 | $28.29 | +35% |
| Q4 2025 | $25.13 | +17% |
| Q3 2025 | $28.52 | +60% |
| Q2 2025 | $27.37 | +39% |
| Q1 2025 | $21.00 | -24% |
| Q4 2024 | $21.50 | -25% |
ABG's earnings per share have fallen from their peak: $25.10 over the past year, against $44.61 in late 2022.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ABG on earnings, with more consistent year-over-year improvement.
ABG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.4B | -8.1% |
| Q2 2026 | $4.4B | +0.3% |
| Q1 2026 | $4.1B | -0.9% |
| Q4 2025 | $4.7B | +3.8% |
| Q3 2025 | $4.8B | +13% |
| Q2 2025 | $4.4B | +3% |
| Q1 2025 | $4.1B | -1.3% |
| Q4 2024 | $4.5B | +18% |
ABG's revenue grew through 2024 and has held roughly level since: $4.4B last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | -0.4 points |
| Q2 2026 | 5% | -0.9 points |
| Q1 2026 | 4.7% | -0.9 points |
| Q4 2025 | 2.7% | -2.6 points |
| Q3 2025 | 5% | -0.4 points |
| Q2 2025 | 5.9% | +3.5 points |
| Q1 2025 | 5.7% | -0.6 points |
| Q4 2024 | 5.3% | +2.1 points |
ABG's operating margin was 4.7% last quarter, about level with the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ABG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ABG on profitability, with a higher operating margin.
ABG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $265.1M | -14% |
| Q2 2026 | $129.4M | +42% |
| Q1 2026 | $223.2M | -0.8% |
| Q4 2025 | $151.9M | -38% |
| Q3 2025 | $306.9M | -24% |
| Q2 2025 | $91.4M | +$245.8M |
| Q1 2025 | $225M | +27% |
| Q3 2024 | $404.3M | +2134% |
ABG has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ABG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -300K shares |
| 1 year | -8.2% | -1.6M shares |
| 3 years | -13% | -2.7M shares |
| 5 years | -7.7% | -1.5M shares |
| Available history | -6.7% | -1.3M shares |
ABG has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $130.6M |
| Q1 2026 | $147M |
| Q4 2025 | $37.2M |
| Q3 2025 | $37.3M |
| Q2 2025 | $200,000 |
| Q1 2025 | $12.5M |
| Q4 2024 | $100,000 |
ABG spent $315M buying back its own shares over the past year, about six times what it spent the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ABG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.4x | Elevated |
ABG's net debt is about 3.9 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over ABG on leverage, with a lower net debt burden relative to earnings.
ABG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 52.0 | Neutral |
ABG's weekly RSI is 50 (neutral) and its Stochastic is 52 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ABG PE vs Consumer Cyclical Sector
| Metric | ABG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 18x | 56% below |
| PE % | 46 | 47 | 1 pt below |
ABG has the edge over AMZN on valuation relative to its sector.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ABG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.0 | 8.5% above |
| 20 week MA | $201.3 | 0.9% below |
| 50 week MA | $208.8 | 4.4% below |
| 100 week MA | $225.2 | 11% below |
| 200 week MA | $224.5 | 11% below |
ABG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 11% below its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over ABG on trend strength, trading above more of its moving averages.
ABG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $113.6 | $139.8 | +23% |
| 2021 | $139.8 | $164.4 | +18% |
| 2022 | $164.4 | $169.0 | +2.8% |
| 2023 | $169.0 | $225.0 | +33% |
| 2024 | $225.0 | $244.5 | +8.7% |
| 2025 | $244.5 | $241.5 | -1.3% |
| 2026 YTD | $241.5 | $199.6 | -17% |
ABG has finished higher in five of the last six years. It's down 17% so far in 2026.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ABG on returns for 2026, with the stronger performance.